These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 16563274

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
    Sheng L, Ye P, Liu YX, Han CG, Zhang ZY.
    Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
    [Abstract] [Full Text] [Related]

  • 3. Atorvastatin attenuating down-regulation of peroxisome proliferator-activated receptor gamma in preventing cardiac hypertrophy of rats in vitro and in vivo.
    Ye P, Sheng L, Zhang C, Liu Y.
    J Pharm Pharm Sci; 2006 Feb; 9(3):365-75. PubMed ID: 17207419
    [Abstract] [Full Text] [Related]

  • 4. Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor Beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro.
    Sheng L, Yang X, Ye P, Liu YX, Han CG.
    Chin Med Sci J; 2015 Dec; 30(4):245-51. PubMed ID: 26960306
    [Abstract] [Full Text] [Related]

  • 5. [Atorvastatin attenuates parathyroid hormone 1-34 induced cardiomyocytes hypertrophy through downregulating K-Ras-ERK1/2 pathway].
    Liu XG, Miao N, Sui MS, Mu SH, Zhao SL, Xie RJ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):1051-5. PubMed ID: 23363723
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
    Tu Y, Wan L, Bu L, Zhao D, Dong D, Huang T, Cheng Z, Shen B.
    Cell Physiol Biochem; 2013 Dec; 31(6):997-1008. PubMed ID: 23860036
    [Abstract] [Full Text] [Related]

  • 7. [The effect of PPARalpha signal channel on atorvastatin inhibiting MMP-9 expression in aging myocytes].
    Han L, Ye P, Li MG.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):469-72. PubMed ID: 24386831
    [Abstract] [Full Text] [Related]

  • 8. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
    Ye P, Yang W, Wu SM, Sheng L.
    Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):691-6. PubMed ID: 17235413
    [Abstract] [Full Text] [Related]

  • 9. In vivo and in vitro protective effects of pentamethylquercetin on cardiac hypertrophy.
    He T, Chen L, Chen Y, Han Y, Yang WQ, Jin MW.
    Cardiovasc Drugs Ther; 2012 Apr; 26(2):109-20. PubMed ID: 22183794
    [Abstract] [Full Text] [Related]

  • 10. Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity.
    Yan L, Zhang JD, Wang B, Lv YJ, Jiang H, Liu GL, Qiao Y, Ren M, Guo XF.
    PLoS One; 2013 Apr; 8(9):e72548. PubMed ID: 24039778
    [Abstract] [Full Text] [Related]

  • 11. [Pioglitazone inhibits cardiac hypertrophy of rats in vitro and in vivo].
    Ye P, Zhang C, Wu SM, Liu YX.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Feb; 21(1):35-9. PubMed ID: 21166160
    [Abstract] [Full Text] [Related]

  • 12. Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation.
    Planavila A, Laguna JC, Vázquez-Carrera M.
    Biochim Biophys Acta; 2005 Feb 21; 1687(1-3):76-83. PubMed ID: 15708355
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
    Pellieux C, Montessuit C, Papageorgiou I, Lerch R.
    Cardiovasc Res; 2009 May 01; 82(2):341-50. PubMed ID: 19131364
    [Abstract] [Full Text] [Related]

  • 14. Atorvastatin prevents peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) downregulation in lipopolysaccharide-stimulated H9c2 cells.
    Planavila A, Sánchez RM, Merlos M, Laguna JC, Vázquez-Carrera M.
    Biochim Biophys Acta; 2005 Sep 15; 1736(2):120-7. PubMed ID: 16139565
    [Abstract] [Full Text] [Related]

  • 15. In vitro modulation of peroxisome proliferator-activated receptor-gamma and its genes by C-reactive protein. Role of atorvastatin.
    Mahajan N, Dhawan V.
    Arch Med Res; 2010 Apr 15; 41(3):154-61. PubMed ID: 20682172
    [Abstract] [Full Text] [Related]

  • 16. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
    Kar D, Bandyopadhyay A.
    Cell Physiol Biochem; 2018 Apr 15; 49(1):245-259. PubMed ID: 30138942
    [Abstract] [Full Text] [Related]

  • 17. [The effect of relgulation of PPAR-α on cardiac hypertrophy and the relationship between the effect of PPAR-α with PI3K/Akt/mTOR pathway].
    Wu Y, Wang BX, Guo YY, Wang YQ.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May 15; 31(3):284-8. PubMed ID: 26387199
    [Abstract] [Full Text] [Related]

  • 18. Use of atorvastatin to inhibit hypoxia-induced myocardin expression.
    Chiu CZ, Wang BW, Shyu KG.
    Eur J Clin Invest; 2012 May 15; 42(5):564-71. PubMed ID: 22129233
    [Abstract] [Full Text] [Related]

  • 19. Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4.
    Sanguino E, Roglans N, Alegret M, Sánchez RM, Vázquez-Carrera M, Laguna JC.
    Br J Pharmacol; 2005 Aug 15; 145(7):853-61. PubMed ID: 15912134
    [Abstract] [Full Text] [Related]

  • 20. Apigenin-induced HIF-1α inhibitory effect improves abnormal glucolipid metabolism in AngⅡ/hypoxia-stimulated or HIF-1α-overexpressed H9c2 cells.
    Zhu ZY, Wang F, Jia CH, Xie ML.
    Phytomedicine; 2019 Sep 15; 62():152713. PubMed ID: 31078968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.